Skip to Content

Quest Diagnostics, Inc. (DGX)

Consumer

Overview
  • Date:
  • 12/16/2016
  • Company Name:
  • Quest Diagnostics
  • Stock Symbol:
  • DGX
  • Status:
  • Closed/Complete

Case Finder

Locate any case using the tools below.

Bragar Eagel & Squire, P.C. is investigating potential claims against Quest Diagnostics, Inc. (NYSE: DGX) for the wrongful disclosure of confidential health and medical information, which was obtained by third-party hackers.

On December 12, 2016, clinical laboratory services company Quest announced that it is investigating a third-party infiltration into an internet application on its network. Quest issued a press release disclosing that on November 26, 2016, an unauthorized third party accessed the MyQuest by Care 360 internet application and obtained confidential health and other information concerning approximately 34,000 patients. The information included names, dates of birth, lab results, and, in some instances, phone numbers.

Quest announced that it sent notifications to those individuals whose information was affected. Quest is working with law enforcement officials and cybersecurity firms to determine the source and cause of the breach.

If you are aware of any facts relating to this investigation, are a user of Quest’s MyQuest by Care360 app, believe you may have been affected by the Quest health data breach, or if you have questions concerning what rights you may have concerning the Quest health data breach, please contact David J. Stone, Esq., by email at investigations@bespc.com, or telephone at (212) 308-5858, or by filling out the contact form below. There is no cost or obligation to you.

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: